Scientists have created a range of p53 gene treatments aimed at different cancer-specific receptors, such as epidermal growth factor receptors [167], folate receptors [48], CD44 receptors [44,152], transferrin receptors [153], neurociliary protein [71], asialoglycoprotein receptors [161], and integrin receptors [97]. The gene discussed is TP53; the disease is cancer.